Lantern Pharma receives USPTO patent allowance for LP-184 biomarker

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/18/2026

1. XENE
2. SPY
3. HUBS
4. NUE
5. RTB
6. ONON
7. AAPL
8. TRMD
9. ACN
10. AZN

Go back to Lantern Pharma receives USPTO patent allowance for LP-184 biomarker
(NASDAQ: LTRN) Delayed: 1.55 -0.16 (9.36%)
Previous Close $1.71    52 Week High $ 
Open $1.75    52 Week Low $ 
Day High $1.75    P/E N/A 
Day Low $1.55    EPS $ 
Volume 189,714